Table 2.

Oncologic and functional outcomes in sRARP series.

Series	Patients, n	Overall complications, n	Rectal injury, n	+LN, n	Continence, n	Potency, n	PSM, n	BCR during follow-up, n
Jamal et al. [25]	1	0	0	0	1/1	NA	0/1	0
Kaouk et al. [22]	4	1	0	0	3/4	NA	2/4	NA
Boris et al. [26]	11	3	0	2	8/11	2/11	3/11	3
Eandi et al. [27]	18	7	0	1	6/18	0/18	5/18	6
Strope et al. [28]	6	4	0	0	0/6	0/6	1/6	2
Chauhan et al. [29]	15	4	0	1	10/14	0/15	2/15	4
Kaffen-berger et al. [30]	34	13	1	0	12/33	5/33	9/34	6
Yuh et al. [32]	51	24	1	3	23/51	6/13	16/51	10

EBL: estimated blood loss; OR: operative; LN: lymph node; PSM: positive surgical margin; BCR: biochemical recurrence; and NA: not available.